An interventional study of Brief Parent Behavioral Intervention and Sleep-Focused Parent Behavioral Intervention in Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Hyperactivity Disorder and Child, Preschool, sponsored by University of Pittsburgh. Active, not recruiting at 7 sites in United States. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-06-09.
Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh — 2 open to participants now, 4 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · University of Pittsburgh.
Among the 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh, this one is the 5th largest by planned enrollment, is the only one that started in 2023, is one of 7 with no phase, and was the 7th registered.
1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.
Browse Attention Deficit Disorder with Hyperactivity studies →2 of the 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh are open now, in 1 country. Recruiting first, the newest first:
University of Pittsburgh · Sites in United States
Ages 18+ · Women only
University of Pittsburgh · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.
This study: 3 Years to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 72 across 1,439 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.
Median enrollment 43 across the 10 interventional studies. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Pittsburgh is the lead sponsor of 1,422 studies on the registry; 170 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
3 of the studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04946253University of PittsburghSKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care | 2026-11 |
| NCT05683756University of PittsburghOptimizing Attention and Sleep Intervention Study | 2026-12 |
| NCT06540547University of PittsburghMoms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Attention Deficit Disorder with Hyperactivity by University of Pittsburgh, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this pilot clinical effectiveness trial is to compare a brief parent behavioral intervention (PBI) to a modified sleep focused PBI (SF-PBI) delivered by therapists in pediatric primary care for families of children 3-5 years old with sleep problems and early ADHD symptoms.
The main aims are to:
Aim 1: Demonstrate the acceptability, feasibility, and appropriateness of the sleep focused PBI (SF-PBI) delivered in pediatric primary care for preschool-aged children (3-5 years old) at elevated risk for ADHD.
Aim 2: Examine change in target engagement (sleep) and ADHD symptoms among preschool-aged children at elevated risk for ADHD receiving SF-PBI compared to standard PBI.
Sleep problems may be one mechanism through which young children may be at risk for developing ADHD, although first line ADHD interventions, including parent behavioral interventions (PBIs), do not address sleep. Investigators will test a modified version of a PBI to target sleep disrupting behaviors for children 3-5 years old at elevated risk for ADHD. The intervention will be delivered by behavioral health therapists embedded in pediatric primary care to increase families' access to intervention. This pilot effectiveness trial is the first step towards developing an early intervention targeting sleep as a mechanism to reduce the prevalence, symptoms, and impairments associated with childhood ADHD.
1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.
This study's planned enrollment of 50 is below the median of 72 across 1,439 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.
Browse Attention Deficit Disorder with Hyperactivity studies →University of Pittsburgh is the lead sponsor of 1,422 studies on the registry; 170 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
Compared within Attention Deficit Disorder with Hyperactivity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Attention Deficit and Disruptive Behavior Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Parent/Caregiver:
Child:
Exclusion Criteria:
A brief parent behavioral intervention with evidenced based strategies for treatment of ADHD.
Behavioral: Brief Parent Behavioral Intervention
A modified version of the brief parent behavioral intervention that specifically targets sleep disrupting behaviors.
Behavioral: Sleep-Focused Parent Behavioral Intervention
PBI administered in pediatric primary care by an embedded therapist.
SF-PBI administered in pediatric primary care by an embedded therapist.
Intervention Acceptability
Therapists and caregiver report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good acceptability.
Time frame: Post Intervention at approximately 4 months
Intervention Appropriateness
Therapists and caregiver report of intervention appropriateness will be assessed using the 4-item Intervention Appropriateness Measure (IAM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good appropriateness.
Time frame: Post Intervention at approximately 4 months
Intervention Feasibility
Therapists and caregiver report of intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good feasibility.
Time frame: Post Intervention at approximately 4 months
Problematic Sleep
Using the Brief Child Sleep Questionnaire caregivers will report on their perception of child's sleep as problematic, rated 1 (Not at all) to 5 (A serious problem).
Time frame: Change from baseline up to 8 months
ADHD Symptoms
Using the 18-item ADHD Rating Scale-IV-Preschool Version caregivers will report on the child's ADHD symptoms. Symptoms are rated from 0 (Rarely) to 3 (Very Often).
Time frame: Change from baseline up to 8 months
Nighttime Awakenings
Caregivers will report how many times their child typically wakes during the night, using the Brief Child Sleep Questionnaire.
Time frame: Change from baseline up to 8 months
Sleep Latency
Sleep latency will be determined by using the caregiver report of how long it typically takes their child to fall asleep (number of minutes), using the Brief Child Sleep Questionnaire.
Time frame: Change from baseline up to 8 months
Consistency of Bedtime Routine
Caregivers will report the number of days, in a typical week, they regularly put their child to bed at the same time (within 15 minutes), using the Brief Child Sleep Questionnaire.
Time frame: Change from baseline up to 8 months
Actigraphy
Actigraphy is collected for 10 days at each of the three study timepoints. These data are to assess feasibility of actigraphy data collection with this population and will be used in exploratory analyses.
Time frame: Change from baseline up to 8 months
Sleep Diary
Sleep diary is collected for 10 days at each of the three study timepoints. These data are to assess feasibility of parent reported sleep diary data collection with this population and will be used in exploratory analyses.
Time frame: Change from baseline up to 8 months
Plan to share: Yes — Individual participant data collected during the trial will be shared, after deidentification, via the NIMH National Data Archive.
Supporting information: Study protocol
Time frame: Data will be shared upon publication or 1 year after the grant end date. Data will be available indefinitely.
Access criteria: Any NIMH NDA authorized users may request the data.
Data sharing details ↗ · nda.nih.gov
Started Dec 2023 (actual). Primary completion is estimated for Dec 2026, 36 months after the start.
Of 480 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 36 months is above that.
Counting every sponsor, half of 511 studies reached it within 23 months; a quarter within 11 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity →